Medicus Pharma Ltd. (MDCXW) Common Equity (2023 - 2026)
Medicus Pharma's (MDCXW) quarterly Common Equity came in at -$67554.0 in Q4 2025, down 102.16% YoY from $3.1 million in Q4 2024, and up 92.58% on a QoQ basis from -$910126.0 in Q3 2025.
Medicus Pharma Ltd. (MDCXW) Common Equity (2023 - 2026) Analysis & Trends
Medicus Pharma (MDCXW) has 3 years of Common Equity data on file, last reported at -$67554.0 in Q4 2025.
- Quarterly Common Equity fell 102.16% year-over-year to -$67554.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$67554.0 (down 102.16% YoY) and the FY2025 annual result came in at -$67554.0, down 102.16% from the prior year.
- Common Equity improved to -$67554.0 in Q4 2025, from -$910126.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $7.1 million in Q2 2024 to a low of -$910126.0 in Q3 2025.
- A 3-year average of $2.2 million and a median of $2.1 million in 2025 frame the typical range for Common Equity.
- The widest YoY moves for Common Equity: up 483.52% in 2025, down 118.98% in 2025.
- Tracing MDCXW's Common Equity over 3 years: stood at $1.1 million in 2023, then jumped by 182.04% to $3.1 million in 2024, then sank by 102.16% to -$67554.0 in 2025.
- The last three Common Equity figures came in at -$67554.0 (Q4 2025), -$910126.0 (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.76 Mn |
| Dec 31, 2025 | -67,554.00 |
| Sep 30, 2025 | -910,126.00 |
| Jun 30, 2025 | 3.25 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | -559,957.00 |
| Dec 31, 2023 | 1.11 Mn |